- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 426757, 8 pages
Behavioral, Neurochemical and Neuroendocrine Effects of Abnormal Savda Munziq in the Chronic Stress Mice
1Traditional Uighur Medicine Department, Xinjiang Medical University, 393 Medical University Road, Urumqi, Xinjiang 830011, China
2Neurology Department, Xinjiang Medical University Affiliation of Traditional Chinese Medicine Hospital, 116 Huanghe Road, Urumqi, Xinjiang 83000, China
3Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Rua de Jorge Viterbo Ferreira 228, 40-50-313 Porto, Portugal
Received 6 April 2012; Revised 1 June 2012; Accepted 18 June 2012
Academic Editor: Paul Siu-Po Ip
Copyright © 2012 Nurmuhammat Amat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Oral administration of Abnormal Savda Munsiq (ASMq), a herbal preparation used in Traditional Uighur Medicine, was found to exert a memory-enhancing effect in the chronic stressed mice, induced by electric foot-shock. The memory improvement of the stressed mice was shown by an increase of the latency time in the step-through test and the decrease of the latency time in the Y-maze test. Treatment with ASMq was found to significantly decrease the serum levels of adrenocorticotropic hormone (ACTH), corticosterone (CORT) and -endorphin (-EP) as well as the brain and serum level of norepinephrine (NE). Furthermore, ASMq was able to significantly reverse the chronic stress by decreasing the brain and serum levels of the monoamine neurotransmitters dopamine (DA), 5-hydroxytryptamine (5-HT) and 3,4-dihydroxyphenylalanine (DOPAC). The results obtained from this study suggested that the memory-enhancing effect of ASMq was mediated through regulations of neurochemical and neuroendocrine systems.
According to the Traditional Uighur Medicine (TUM), the abnormal Savda syndrome can be caused by exogenous (environmental, psychological, and emotional) as well as endogenous stimuli or stressors . We thus hypothesized, in terms of modern medicine, the etiology and pathogenesis of abnormal Savda syndrome as the state under stress conditions whose symptoms, manifested in the clinical conditions of chronic diseases, include mental stress, tantrum, hypomnesis, dry skin, polydipsia, polyphagia, and memory dysfunction .
Abnormal Savda Munsiq (ASMq) is a well-known complex prescription of Traditional Uighur Medicine for abnormal Savda which consists of crude drugs of ten medicinal herbs: Adiantum capillus-veneris L. Alhagi pseudalhagi (Bieb.) Desv., Anchusa italica Retz., Cordia dichotoma G. Forst., Euphorbia maculata L., Foeniculum vulgare Mill., Glycyrrhiza glabra L., Lavandula angustifolia Mill., Melissa officinalis L., and Ziziphus jujuba Mill. ASMq is widely used in the prevention and treatment of many chronic diseases such as cancer, hypertension, diabetes mellitus, and memory dysfunction, the diseases which are associated with abnormal Savda Hilit and whose symptomatic expression is known as abnormal Savda Syndrome .
It is well established that the disruption of the hypothalamus-pituitary-adrenal (HPA) axis, a central pathway to the entire endocrine system, is often central to most health problems, syndromes, diseases, and even aging itself [4–6]. Hyperactive status of the HPA axis can result in increasing levels of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and glucocorticoids in the hypothalamus, pituitary, and adrenal cortex, respectively [7, 8]. On the one hand, stress can also alter the physiological homeostasis which can result in various neuronal, endocrine, and visceral dysfunctions . Furthermore, stress is also known to alter cognitive functions, such as memory, and it has been linked to the pathophysiology of mood and anxiety disorders [7, 10]. A central feature of the stress response is the activation of the HPA axis which can result in an increase in plasma levels of glucocorticoids . As a consequence of their profound effects on neurons, glucocorticoids can influence behavior, mood, and memory process [12, 13]. Neurotransmitter systems are also involved in learning and memory processes, and a substantial part of learning and memory impairments is due to changes in neurotransmission . It is well established that neurotransmitters can interfere with learning acquisition and memory . In this context, the memory dysfunction described in abnormal Savda syndrome could involve an excessive production of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and glucocorticoids in the hypothalamus, pituitary, and adrenal cortex, respectively, under the stress condition.
Although ASMq has been previously investigated pharmacologically and clinically for its antioxidant , immunomodulatory , and anticancer activities  as well as for its protective effects against radiation-induced and oxidative stress-induced damages [17–20], its potential protective effects against neurological hormone imbalance have never been systematically evaluated. Therefore, in our continuing effort to support the therapeutic values of Traditional Uighur Medicine (TUM), we have further evaluated the effects of ASMq on memory capability and concomitant biochemical parameters, such as neurotransmitters (ACTH, CORT, and β-EP), as pathophysiological indicators involved in the chronic stress mice model. The selected model is based on the fact that psychological chronic stress-induced (electric foot-shock) pathophysiology is similar to the conditions of abnormal Savda syndrome described in the ancient theory of TUM.
2. Materials and Methods
Mice adrenocorticotropin (ACTH), corticosterone (CORT), and β-endorphin (β-EP) kits were obtained from R&D Systems, USA. Norepinephrine (NE, purity ≥ 97%), dopamine (DA, purity ≥ 99%), 5-hydroxytryptamine (5-HT, purity ≥ 99%), 3,4–dihydroxyphenylamine (DOPAC, purity ≥ 99%),and 3,4-dihydroxybenzylamine (DHBA, purity ≥ 98%) were obtained from Sigma Co., Ltd., USA. All other reagents were of analytical grade.
2.2. Preparation of the Aqueous Extract of ASMq
Plant materials for ASMq (Table 1) were purchased from Xinjiang Uighur Autonomous Region Traditional Uighur Medicine Hospital in Urumqi (China) and authenticated by Pharmacist Abuduwar of the Uighur Medicine Preparation Center of Xinjiang Autonomous Region Traditional Uighur Medicine Hospital. The voucher specimens (070818) were deposited at the herbarium of this Preparation Center. Briefly, all the herbs were chopped into small pieces and ground. The powdered material (1 kg) was macerated in warm distilled water (10 L) at 80°C for 12 h. The solution was then boiled for 30 min and left to stand for 1 h before filtration. The filtrate was then concentrated to semisolid mass under reduced pressure and dried at 60°C under vacuum condition. The yield of the extract was 29.4% (w/w) of the dried plant materials. The extract was dissolved in 0.5% sodium carboxymethyl cellulose (CMC-Na) solution and administered to the mice according to the experimental dosages.
The pathogen-free ICR male mice weighing 18–20 g (Xinjiang Medical University Animal Center, Urumqi, China) were kept under condition of controlled temperature (24°C) and illumination (12 h light cycle) and were maintained on laboratory standard diet and water freely. The animals were divided randomly into five groups of 10 mice. The mice were kept under laboratory condition for 3 days before drug administration. The mice of normal group (Gr. I) were housed and fed in the normal condition. The chronic stress was induced in mice by application of the electric-foot shock. The stress model group (Gr. II) received the repeated electric foot-shock (volume 20–30 V, interval 0.2–0.5 s during 20 min/day) in the electric foot-shock instrument before being housed in the climatic cabinet from 8:30 am–10:30 pm (at 6°C and 25–32.8% of relative humidity). The experimental procedures were approved by the guidelines of the Animal Care and Use Committee of Xinjiang Uighur Autonomous Region.
2.4. Drug Administration
0.5% Sodium carboxyl methyl cellulose (CMC-Na) solution (20 mL/kg, b.w.) was administered orally to the normal (Gr. I) and the stress model (Gr. II) mice once a day during 14 days. Another groups of mice received ASMq solution orally at the dose of 2.53 g/kg (Gr. IIIa), 5.06 g/kg (Gr. IIIb), and 10.12 g/kg (Gr. IIIc), respectively, between 7:30 am–9:30 am daily during 14 days. These doses were calculated according to the conversion table of equivalent effective dose ratios from human to animals based on the body surface area. Food was withdrawn from the animals 2 h prior to drug administration but water was allowed freely. The ASMq pretreatment groups (Gr. IIIa, IIIb, and IIIc) received the same electric foot-shock one hour after drug administration (8:30 am–10:30 am).
2.5. Determination of Memory Capacity by the Y-Maze Task and the Passive Avoidance Task
2.5.1. Y-Maze Task
The Y-maze task test was performed as previously described by Munck et al. . The Y-maze apparatus with a conductive grid floor consisted of three identical arms (40 L × 10 w × 20 h cm) made of dark opaque Plexiglas and positioned at equal angles. Arms 1 and 3 were in the non-safety zone (where shocks were administered) while arm 2 was in a safety zone (on top of which there was an insulated grid floor of 10 × 15 cm). The test was conducted in two consecutive days at the same time of the day (after 14 days of oral administration with ASMq for Gr. IIIa, IIIb, and IIIc). On the first day, each mouse was placed on the top of arm 1, and a fixed resistance shock source was connected to an automatically operated switch, and electric shocks (36 V) were applied. After shocking, the mice escaped from foot-shocks by accidentally entering the top of arm 2 and this was counted as one practice and the mice were repeatedly trained for this procedure for ten more times. After a 24 h interval, the mice were successively tested ten times and their latency time to enter the safety zone (i.e., insulated grid floor) from non-safety zone for the first time and the number of errors displayed by entering the non-safety zone within ten repetitions were recorded as learning performances.
2.5.2. Passive Avoidance Task: Step-Through Test
A passive avoidance reflex apparatus was provided by Xinjiang Medical University (Urumqi, China), which was separated into a lightened chamber (11 cm × 3.2 cm) and a dark chamber (17 cm × 3.2 cm), with a connecting tunnel and copper grids on the floor. The test was conducted in two consecutive days at the same time of the day (after 14 days of oral administration with different doses of ASMq for Gr. IIIa, IIIb, and IIIc). On the first day, each mouse was placed in the illuminated compartment. Each mouse received a learning trial 24 h before the test. Mice were placed into the lightened chamber and on stepping through the tunnel into the dark chamber; they would suffer a 40 V electric stimulation (in order to condition them to stay in the lightened chamber) and escape out of the dark chamber. 24 h later, mice were placed into the lightened chamber again and the latency time of mice staying in the lightened chamber and the number of times they entered the dark chamber within 5 min were recorded to evaluate their memory capacity.
2.6. Measurements of Adrenocorticotropin (ACTH), Corticosterone (CORT), and β-Endorphin (β-EP)
On the last day of drug administration, the blood was collected and centrifuged at 4°C; the serum was stored at −80°C before assay. Serum levels of ACTH, CORT, and β-EP were determined using ELISA kit (obtained from R&D Systems). The sensitivity of the assay was 1.0 ng/mL. Intra-assay and inter-assay coefficients of variation were less than 4.85% and 6.08%, respectively. The test was performed according to the manufacturer’s specification.
2.7. Measurements of Monoamine Neurotransmitters by HPLC-FCD
Levels of monoamine neurotransmitters (NE, DA, 5-HT, and DOPAC) in serum and brain were measured by HPLC coupled with a fluorescence detector (FCD). Mice were sacrificed immediately after exposure to the stress. Blood was sampled into EDTA-containing tubes at 10:00 am, and separated in a refrigerated centrifuge at 10,000 ×g for 10 min at 4°C. The serum was stored at −80°C until assayed. After blood collection, the brains were quickly removed, frozen in liquid nitrogen, and stored at −80°C until assayed. To determine serum monoamine neurotransmitter levels, an equal volume of 0.1 M HCl was added to the serum samples containing 200 μg/mL of DHBA as an internal standard. The samples were then shaken and mixed for 1.5 min in ice water. One drop of concentrated HCl was then added to the solution and mixed in ice water for another 1.5 min and then centrifuged at 3000 rpm, 4°C for 10 min. The samples of brain tissue were homogenized in ice water solution of 0.1 M HCl. Then, 0.1 M HCl solution was added to the samples (1 μL/1 mg tissue) containing 200 μg/mL of DHBA as an internal standard and centrifuged at 18000 rpm, 4°C for 10 min. The samples were filtered through 0.45 μm microfilters (MFS Inc., USA). Aliquots (10 μL) of supernatant were injected into a reverse phase HPLC column (condition: Agilent 110180 high-voltage pump coupled to a fluorescence detector, chromatographic column ZORBAX ODB C18 4.6 mm × 150 mm × 5 mm, voltage 121 V, and wavelength 360 nm). All the brain samples were weighed on an electronic scale prior to HPLC analysis, and the results were expressed as ng of monoamine/mg of wet weight tissue.
2.8. Statistical Analysis
Data were expressed as the mean ± standard error of the mean (SEM). The statistical significance of the differences between the groups was analyzed by one-way analysis of variance (ANOVA) following by least significant difference (LSD) tests. All statistical calculations were performed using SPSS v13.0. Value of P < 0.05 was considered to be significant.
3.1. Effects of ASMq on Memory Capability in Stress Mice
In the Y-maze task test, the latency time and number of errors of the chronic stress mice (Gr. II) were found to be markedly increased when compared to the normal group (Gr. I). In contrast, mice treated with ASMq, by oral administration, at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg (Gr. IIIa, IIIb, and IIIc) for 14 days showed an improvement of a memory as evidenced by a decrease of the latency time and the number of errors (Figure 1). On the other hand, in the passive avoidance task, the chronic stress mice (Gr. II) showed a significant decrease of the latency time and an increase in the number of errors when compared to the normal group (Gr. I). Oral administration with ASMq at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg (Gr. IIIa, IIIb, and IIIc) for 14 days has boosted the memory capability as indicated by an increase of latency time and a decrease of the number of errors (Figure 2).
3.2. Effects of ASMq on the Serum Levels of ACTH, CORT, and β-EP in the Chronic Stress Mice
Table 2 showed that the serum levels of ACTH, CORT, and β-EP were markedly increased (P < 0.01) in the chronic stress mice (Gr. II) when compared to the normal group (Gr. I). Oral administration of ASMq at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg (Gr. IIIa, IIIb, and IIIc) for 14 days caused a decrease of the levels of ACTH, CORT, and β-EP in the serum when compared to the model group (Gr. II).
3.3. Effects of ASMq on the Contents of Monoamine Neurotransmitters of Brain and Serum in the Chronic Stress Mice
Figures 3 and 4 showed an increase (P < 0.05) of NE level in the serum of the chronic stress mice (Gr. II) and a decrease of the serum levels of DA, 5-HT, and DOPAC (P < 0.01), when compared to the normal group (Gr. I). Oral administration of ASMq during 14 days at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg (Gr. IIIa, Gr. IIIb, and Gr. IIIc) was able to decrease the NE levels (P < 0.01), while the levels of DA, 5-HT, and DOPAC were increased (P < 0.05).
Figures 5 and 6 showed similar results with an increase of the NE level (P < 0.01) but a decrease in the levels of DA and DOPAC (P < 0.01) in the brain of the chronic stress mice (Gr. II), when compared to the normal group (Gr. I). However, there were no statistically significant differences in the levels of 5-HT between the stress mice (Gr. II) and the normal group (Gr. I). All doses of ASMq (2.53 g/kg, 5.06 g/kg, and 10.12 g/kg) were found to reduce the concentration of NE in the brain (P < 0.01) when compared to the stress mice (Gr. II). In contrast, only the dosages of 5.06 g/kg and 10.12 g/kg of ASMq (Gr. IIIb and IIIc) could raise the levels of DA in the brain (P < 0.05) of the stress mice (Gr. II) while the concentrations of DOPAC in the brain were increased with all doses of ASMq (P < 0.05).
It is generally accepted today that there is a strong link between stressful experiences and altered neurochemistry, endocrinology, and immunology , and it is also well established that unpredictable and uncontrollable stressful events can affect cognitive processes. However, only hippocampus-mediated memory processes are thought to be sensitive to the effects of chronic stress.
Many studies of nootropic (memory-enhancing) drugs use step-down, step-through, maze test, and so forth, which are often applied to the determination of capabilities of passive avoidance and spatial memory in animals to investigate their behavior changes. For this reason, we used the Y-maze task and the passive avoidance task tests to evaluate of the effects of ASMq on the memory capability of the stress mice model. Figures 1 and 2 show an improvement in learning performances of aged mice receiving ASMq by an increased latency and a decreased number of errors in the step-through test, as well as by a shortened latency and a decreased number of errors in the Y-maze test.
In contrast, the hippocampus-independent memory processes have been shown to be resistant to chronic stressful experiences . Generally, two systems are being considered in the pathogenesis of memory dysfunction—the hormones of the sympathetic nervous system (adrenalin and noradrenalin) and the hormones of the HPA axis (CRH, ACTH, and CORT). These stress-responsive systems interact at multiple levels in the periphery and in the brain, and together, they influence memory in a complex manner. Many neurotransmitters, including acetylcholine, dopamine (DA), norepinephrine (NE), and serotonin (5-HT), are found to play an important role in the learning and memory processes, and some monoamines are also known to be potent activators of the HPA axis . NE is considered to be relevant to learning and memory consolidation, possibly by acting as a coordinator of signals . It can also control the release of CRH in the hypothalamus and hence an ACTH mediator of the acute stress response and HPA axis, respectively. The catecholamine system, especially DA, has been also implicated in learning and memory process; however, excessive or insufficient levels of DA can lead to impairment . It has been shown that DA has a beneficial impact on spatial working memory  and motivational processes  while serotonin (5-HT) may be seen also as a crucial “fine tuner” of normal and pathological processes in addition to having a role as a conventional neurotransmitter . Clinical and experimental evidences have suggested that 5-HT is involved in the regulation of mood, sleep, memory, learning, and behavior, all of which are deranged to varying extents in patients with severe depression . Furthermore, 5-HT has been linked to emotional processes , and it was found to play a particular role in emotionally related tasks. Despite the lack of functional specialization, the serotonergic system can play a significant role in learning and memory . The function of HPA axis and 5-HT is intimately linked, and 5-HT is found to participate in modulating the HPA axis . The results of our study have corroborated this proposal. Table 2 showed that the levels of ACTH, CORT, and β-EP were dramatically increased in the electric foot-shock-induced chronic stress mice and oral administration of ASMq at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg for 14 days was able to reverse the levels of these hormones. Our finding is particularly relevant since it is also well known that cognitive deficits induced by various lesions to the locus are reversible by administration of drugs that enhance noradrenergic neurotransmission.
Our results showed also that oral administration of ASMq at doses of 2.53 g/kg, 5.06 g/kg, and 10.12 g/kg clearly regulated the serum and brain monoamine neurotransmitter levels after alteration induced by chronic electric foot-shock. These findings demonstrate that the brain and serum levels of NE were decreased whereas those of DA and DOPAC were markedly increased (Figures 3, 4, 5, and 6). Although the serum levels of 5-HT were found to be markedly increased, the levels of 5-HT in the brain were not statistically different (P > 0.05) between the model (Gr. II) and the normal groups (Gr. I).
Considering the composition of ASMq, it is pertinent to mention also that the chemical constituents of the ten herbal drugs used in the preparation could contribute to its capacity to restore memory and cognitive function of the stress mice. For example, flavonoids have been reported as constituents of Adiantum capillus-veneris , Euphorbia maculata , and Zizyphus jujuba , and emerging evidence suggested that they may exert beneficial effects on the central nervous system by protecting neurons against stress-induced injury, by suppressing neuroinflammation, and by improving cognitive function. It is likely that flavonoids exert such effects, through selective actions on different components of a number of protein kinases and lipid kinase signaling cascades, such as the phosphatidylinositol-3 kinase (PI3 K)/Akt, protein kinase C, and mitogen-activated protein kinase (MAPK) pathways rather than via their potential to act as classical antioxidants . It was also reported that daily oral administration of flavonoids (35 mg/kg, for 19-20 days), isolated from aerial parts of Scutellaria baicalensis Georgi, could reduce memory dysfunction and neuronal injury caused by permanent global ischemia in rats . Another group of phytochemicals is saponins which are constituents of Anchusa italica  and Glycyrrhiza glabra [40, 41]. Previous reports have demonstrated that they could be responsible for improvement of the learning impairment . Zhang et al.  have found that tenuifolin, extracted from radix polygalae, was able to significantly enhance learning performances in aged mice by the step-down and Y-maze tasks. They have suggested that the improvement of learning and memory of aged mice was mediated by the effects of tenuifolin on the three stages of memory process, that is, acquisition, consolidation, and retrieval by relatively increasing the levels of NE, DA in the hippocampus and by decreasing the activity of acetylcholine esterase in the cortex. Interestingly, essential oil, which is a major constituent of Melissa officinalis and Lavandula angustifolia , can also exert its function on learning and memory processes. Zhang et al.  have reported the ameliorating effects of essential oil from Acori graminei rhizoma on learning and memory in aged rat and mice. By investigating the levels of cerebral neurotransmitters, they have suggested that essential oil improved cognitive function in aged rats possibly by increasing NE, DA, and 5-HT relative levels, as well as by decreasing the activity of acetylcholine esterase in the cerebra. Not surprisingly, Melissa officinalis, a herbal drug of the traditional medicine in many cultures, has been attributed with memory-enhancing properties. Interestingly, the ethanol crude extract of Melissa officinalis leaves was shown to be able to modulate mood and cognitive performance during acute administration in healthy young volunteers . Finally, the aqueous extract of Lavandula angustifolia flowers was found to significantly block glutamate-induced neurotoxicity  while the methanolic extract of the whole plant of Foeniculum vulgare could ameliorate the amnesic effect of scopolamine and aging-induced memory deficit in mice , and administration of Foeniculum vulgare extract was able to increase step-down latency and inhibit significantly acetylcholine esterase.
The results of this study have demonstrated that the effects of ASMq on the HPA axis dysfunction and memory deficits, induced by chronic stress, may be related to its modulating effects on neuroendocrine and monoamine neurotransmitters. In addition to supporting traditional claims and the previously reported antichronic disease properties, this study also suggests that ASMq may prevent HPA hyperactivity induced by chronic stress. Oral administration of ASMq to the chronic stress mice was found to significantly enhance their learning performance by the step-through and Y-maze tasks. Interestingly, these effects were found to be concomitant with the regulation of monoamine neurotransmitter levels in their serum and brain. The capacity of ASMq in regulating neurochemicals and neuroendocrine system could be attributed to the presence of particular types of phytochemicals belonging to the herbal drugs constituting the ASMq preparation.
Work in China was supported by the National Natural Science Foundation of China (no: 30260128). Amat thanks the Eurasia-Pacific Uninet (EPU) for a postdoctoral scholarship.
- H. Upur and A. Yusup, The Theory of Mizaj and Hilit of Traditional Uighur Medicine Modern Study on Mizaj and Its Modern Study, Xinjiang Science and Technology Publishing House, Xinjiang, China, 2003.
- H. Upur, A. Yusup, A. Umar, and N. Moore, “Uighur traditional medicine syndrome of abnormal savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of abnormal savda,” Therapie, vol. 59, no. 4, pp. 483–484, 2004.
- N. Amat, H. Upur, A. Ablimit, A. Matsidik, A. Yusup, and A. Kijjoa, “Immunomodulatory effects of abnormal savda Munsiq, a traditional Uighur medicine, on the combined stress mice,” Journal of Ethnopharmacology, vol. 122, no. 1, pp. 42–47, 2009.
- R. M. Reynolds, K. E. Chapman, J. R. Seckl, B. R. Walker, P. M. McKeigue, and H. O. Lithell, “Skeletal muscle glucocorticoid receptor density and insulin resistance,” Journal of the American Medical Association, vol. 287, no. 19, pp. 2505–2506, 2002.
- A. M. V. Ward, C. H. D. Fall, C. E. Stein et al., “Cortisol and the metabolic syndrome in South Asians,” Clinical Endocrinology, vol. 58, no. 4, pp. 500–505, 2003.
- J. P. Girod and D. J. Brotman, “Does altered glucocorticoid homeostasis increase cardiovascular risk?” Cardiovascular Research, vol. 64, no. 2, pp. 217–226, 2004.
- G. Gerra, A. Zaimovic, G. G. Mascetti et al., “Neuroendocrine responses to experimentally-induced psychological stress in healthy humans,” Psychoneuroendocrinology, vol. 26, no. 1, pp. 91–107, 2001.
- J. K. Sluiter, M. H. W. Frings-Dresen, A. J. van der Beek, and T. F. Meijman, “The relation between work-induced neuroendocrine reactivity and recovery, subjective need for recovery, and health status,” Journal of Psychosomatic Research, vol. 50, no. 1, pp. 29–37, 2001.
- H. Shivakumar, T. Javed, T. Prakash, R. Nagendra Rao, B. H. M. J. Swamy, and A. V. Goud, “Adaptogenic activity of ethanolic extract of Tribulus terrestris L,” Journal of Natural Remedies, vol. 6, no. 1, pp. 87–95, 2006.
- L. Song, W. Che, W. Min-Wei, Y. Murakami, and K. Matsumoto, “Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress,” Pharmacology Biochemistry and Behavior, vol. 83, no. 2, pp. 186–193, 2006.
- B. Adinoff, K. Junghanns, F. Kiefer, and S. Krishnan-Sarin, “Suppression of the HPA axis stress-response: implications for relapse,” Alcoholism, Clinical and Experimental Research, vol. 29, no. 7, pp. 1351–1355, 2005.
- L. E. Carlson and B. B. Sherwin, “Steroid hormones, memory and mood in a healthy elderly population,” Psychoneuroendocrinology, vol. 23, no. 6, pp. 583–603, 1998.
- O. M. Wolkowitz, “Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids,” Psychoneuroendocrinology, vol. 19, no. 3, pp. 233–255, 1994.
- G. Wenk, D. Hughey, V. Boundy, A. Kim, L. Walker, and D. Olton, “Neurotransmitters and memory: role of cholinergic, serotonergic, and noradrenergic systems,” Behavioral Neuroscience, vol. 101, no. 3, pp. 325–332, 1987.
- E. Nowakowska, A. Chodera, K. Kus, P. Nowak, and R. Szkilnik, “Reversal of stress-induced memory changes by moclobemide: the role of neurotransmitters,” Polish Journal of Pharmacology, vol. 53, no. 3, pp. 227–233, 2001.
- A. Yusup, H. Upur, I. Baudrimont et al., “Cytotoxicity of abnormal savda Munziq aqueous extract in human hepatoma (HepG2) cells,” Fundamental and Clinical Pharmacology, vol. 19, no. 4, pp. 465–472, 2005.
- A. Yusup, H. Upur, A. Umar, and N. Moore, “Protective effects of Munziq and Mushil of abnormal savda to mitochondrial oxidative damage,” Fundamental and Clinical Pharmacology, vol. 18, no. 4, pp. 471–476, 2004.
- A. Yusup and H. Upur, “Antioxidant effects of Munziq and Mushil of abnormal savda by electron paramagnetic resonance,” Traditional Chinese Drug Research & Clinical Pharmacology, vol. 6, pp. 420–422, 2001.
- L. Zhang, U. Hamurat, and L. Zhang, “Protective effect of abnormal savda munzip on radiation-induced damage in mice,” Zhong Nan Da Xue Xue Bao, vol. 32, no. 1, pp. 69–73, 2007.
- S. Y. Xu, R. L. Bian, and X. Chen, Experimental Methodology of Pharmacology (Third Version), Peoples' Medical Publishing House, Beijing, China, 2002.
- A. Munck, P. M. Guyre, and N. J. Holbrook, “Physiological functions of glucocorticoids in stress and their relation to pharmacological actions,” Endocrine Reviews, vol. 5, no. 1, pp. 25–44, 1984.
- F. Ohl and E. Fuchs, “Differential effects of chronic stress on memory processes in the tree shrew,” Cognitive Brain Research, vol. 7, no. 3, pp. 379–387, 1999.
- T. Myhrer, “Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks,” Brain Research Reviews, vol. 41, no. 2-3, pp. 268–287, 2003.
- T. J. Crow, “Cortical synapses and reinforcement: a hypothesis,” Nature, vol. 219, no. 5155, pp. 736–737, 1968.
- J. Zahrt, J. R. Taylor, R. G. Mathew, and A. F. T. Arnsten, “Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance,” Journal of Neuroscience, vol. 17, no. 21, pp. 8528–8535, 1997.
- M. Bubser and W. J. Schmidt, “6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze,” Behavioural Brain Research, vol. 37, no. 2, pp. 157–168, 1990.
- C. Wilson, G. G. Nomikos, M. Collu, and H. C. Fibiger, “Dopaminergic correlates of motivated behavior: importance of drive,” Journal of Neuroscience, vol. 15, no. 7, pp. 5169–5178, 1995.
- Y. Xu, B. S. Ku, H. Y. Yao et al., “The effects of curcumin on depressive-like behaviors in mice,” European Journal of Pharmacology, vol. 518, no. 1, pp. 40–46, 2005.
- J. Szelényi and Z. Selmeczy, “Immunomodulatory effect of antidepressants,” Current Opinion in Pharmacology, vol. 2, no. 4, pp. 428–432, 2002.
- S. Hashimoto, T. Inoue, and T. Koyama, “Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats,” European Journal of Pharmacology, vol. 378, no. 1, pp. 23–30, 1999.
- M. C. Buhot, S. Martin, and L. Segu, “Role of serotonin in memory impairment,” Annals of Medicine, vol. 32, no. 3, pp. 210–221, 2000.
- M. Naughton, J. B. Mulrooney, and B. E. Leonard, “A review of the role of serotonin receptors in psychiatric disorders,” Human Psychopharmacology, vol. 15, no. 6, pp. 397–415, 2000.
- F. Pourmorad, S. J. Hosseinimehr, and N. Shahabimajd, “Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants,” African Journal of Biotechnology, vol. 5, no. 11, pp. 1142–1145, 2006.
- Y. Amakura, K. Kawada, T. Hatano et al., “Four new hydrolyzable tannins and an acylated flavonol glycoside from Euphorbia maculata,” Canadian Journal of Chemistry, vol. 75, no. 6, pp. 727–733, 1997.
- A. M. Pawlowska, F. Camangi, A. Bader, and A. Braca, “Flavonoids of Zizyphus jujuba L. and Zizyphus spina-christi (L.) Willd (Rhamnaceae) fruits,” Food Chemistry, vol. 112, no. 4, pp. 858–862, 2009.
- J. P. E. Spencer, “Flavonoids: modulators of brain function?” British Journal of Nutrition, vol. 99, no. 1, pp. ES60–ES77, 2008.
- Y. Shang, J. Cheng, J. Qi, and H. Miao, “Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats,” Pharmacology Biochemistry and Behavior, vol. 82, no. 1, pp. 67–73, 2005.
- F. Mojab, M. Kamalinejad, N. Ghaderi, and H. R. Vahidipour, “Phytochemical screening of some species of Iranian plants,” Iranian Journal of Pharmaceutical Research, vol. 2, no. 2, pp. 77–82, 2003.
- I. P. Varshney, D. C. Jain, and H. C. Srivastava, “Study of saponins from Glycyrrhiza glabra root,” International Journal of Crude Drug Research, vol. 21, no. 4, pp. 169–172, 1983.
- S. H. Jin, J. K. Park, K. Y. Nam, S. N. Park, and N. P. Jung, “Korean red ginseng saponins with low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced learning disability and spatial working memory in mice,” Journal of Ethnopharmacology, vol. 66, no. 2, pp. 123–129, 1999.
- H. Wagner, S. Bladt, and E. M. Zgainski, Plant Drug Analysis, Springer, Berlin, Germany, 1984.
- H. Zhang, T. Han, L. Zhang et al., “Effects of tenuifolin extracted from radix polygalae on learning and memory: a behavioral and biochemical study on aged and amnesic mice,” Phytomedicine, vol. 15, no. 8, pp. 587–594, 2008.
- D. O. Kennedy, G. Wake, S. Savelev et al., “Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties,” Neuropsychopharmacology, vol. 28, no. 10, pp. 1871–1881, 2003.
- H. Zhang, T. Han, C. H. Yu, K. Rahman, L. P. Qin, and C. Peng, “Ameliorating effects of essential oil from Acori graminei rhizoma on learning and memory in aged rats and mice,” Journal of Pharmacy and Pharmacology, vol. 59, no. 2, pp. 301–309, 2007.
- M. E. Büyükokuroǧlu, A. Gepdiremen, A. Hacimüftüoǧlu, and M. Oktay, “The effects of aqueous extract of Lavandula angustifolia flowers in glutamate-induced neurotoxicity of cerebellar granular cell culture of rat pups,” Journal of Ethnopharmacology, vol. 84, no. 1, pp. 91–94, 2003.
- H. Joshi and M. Parle, “Cholinergic basis of memory-strengthening effect of Foeniculum vulgare Linn.,” Journal of Medicinal Food, vol. 9, no. 3, pp. 413–417, 2006.